【レポートの概要（一部）】
1 Introduction (Page No. – 16)
1.1 Objectives of the Study
1.2 Market Definition
1.2.1 Market Segmentation
1.2.2 Years Considered for the Study
1.3 Currency
1.4 Limitation
1.5 Market Stakeholders
2 Research Methodology (Page No. – 19)
2.1 Market Size Estimation
2.2 Market Breakdown and Data Triangulation
2.3 Market Share Estimation
2.4 Key Data From Secondary Sources
2.5 Key Data From Primary Sources
2.6 Key Industry Insights
2.7 Assumptions for the Study
3 Executive Summary (Page No. – 27)
3.1 Introduction
3.2 Current Scenario
3.3 Future Outlook
3.4 Conclusion
4 Premium Insights (Page No. – 31)
4.1 Global Vaccines Market
4.2 Vaccines Market, By Type
4.3 Geographic Analysis: Market, By End User
4.4 Geographic Analysis: Market, By Technology
4.5 Geographical Snapshot of the Market
4.6 Lifecycle Analysis, By Region, 2016
5 Market Overview (Page No. – 36)
5.1 Introduction
5.2 Market Segmentation
5.3 Market Dynamics
5.3.1 Drivers
5.3.1.1 High Prevalence of Diseases
5.3.1.2 Rising Government and Non-Government Funding for Vaccine Development
5.3.1.3 Increasing Investments By Companies
5.3.1.4 Increasing Government Focus on Immunization Programs
5.3.2 Restraints
5.3.2.1 Huge Capital Investments
5.3.2.2 Stringent Regulations
5.3.3 Opportunities
5.3.3.1 High Growth Prospects in Emerging Markets
5.3.3.2 Therapeutic Vaccines
5.3.3.3 Adjuvant Vaccines
5.3.4 Challenges
5.3.4.1 Inadequate Access to Vaccines
5.3.4.2 Vaccine Pricing
5.3.5 Burning Issues
5.3.5.1 Vaccine Failure
5.4 Investment Analysis
5.5 Regulatory Landscape
5.5.1 North America
5.5.2 Europe
5.5.3 Asia
5.5.4 RoW
5.6 Patent Analysis
5.7 Key Pipeline Products
6 Vaccines Market, By Technology (Page No. – 57)
6.1 Introduction
6.2 Conjugate Vaccines
6.3 Inactivated and Subunit Vaccines
6.4 Live Attenuated Vaccines
6.5 Toxoid Vaccines
6.6 Recombinant Vaccines
7 Vaccines Market, By Type (Page No. – 66)
7.1 Introduction
7.2 Monovalent Vaccines
7.3 Multivalent Vaccines
8 Vaccines Market, By Disease Indication (Page No. – 71)
8.1 Introduction
8.2 Pneumococcal Disease
8.3 DTP
8.4 Influenza
8.5 Human Papilloma Virus
8.6 Meningococcal Disease
8.7 Polio
8.8 Rotavirus
8.9 Hepatitis
8.10 MMR
8.11 Varicella
8.12 Others
9 Vaccines Market, By End User (Page No. – 87)
9.1 Introduction
9.2 Pediatrics
9.3 Adults
10 Vaccines Market, By Region (Page No. – 92)
10.1 Introduction
10.2 North America
10.2.1 U.S.
10.2.2 Canada
10.3 Europe
10.3.1 Germany
10.3.2 U.K.
10.3.3 France
10.3.4 Italy
10.3.5 Spain
10.3.6 Rest of Europe (RoE)
10.4 Asia
10.4.1 Japan
10.4.2 China
10.4.3 India
10.4.4 Rest of Asia (RoA)
10.5 Rest of the World (RoW)
11 Competitive Landscape (Page No. – 120)
11.1 Overview
11.2 Market Share Analysis
11.3 Competitive Situation and Trends
11.3.1 Agreements, Collaborations, and Partnerships
11.3.2 Regulatory Approvals
11.3.3 Acquisitions
11.3.4 Expansions
11.3.5 Other Developments
12 Company Profiles (Page No. – 127)
(Introduction, Products & Services, Strategy, & Analyst Insights, Developments, MnM View)*
12.1 Introduction
12.2 Pfizer, Inc.
12.3 Glaxosmithkline, PLC.
12.4 Merck & Co., Inc.
12.5 Sanofi Pasteur
12.6 CSL Limited
12.7 Emergent Biosolutions, Inc.
12.8 Johnson & Johnson
12.9 Medimmune, LLC. (A Subsidiary of Astrazeneca)
12.10 Astellas Pharma Inc.
12.11 Serum Institute of India
*Details on Marketsandmarkets View, Introduction, Product & Services, Strategy, & Analyst Insights, New Developments Might Not Be Captured in Case of Unlisted Companies.
13 Appendix (Page No. – 151)
13.1 Insights of Industry Experts
13.2 Discussion Guide
13.3 Knowledge Store: Marketsandmarkets’ Subscription Portal
13.4 Introducing RT: Real-Time Market Intelligence
13.5 Available Customizations
13.6 Related Reports
List of Tables (89 Tables)
Table 1 Incidence of Diseases, 2014-2015
Table 2 Nih Funding for Vaccine Research, 2012-2016 (USD Million)
Table 3 High Prevalence of Diseases to Boost the Vaccines Market
Table 4 Huge Capital Investments to Limit the Market Growth of Vaccines
Table 5 High Growth Potential in Emerging Countries to Boost the Market for Vaccines
Table 6 Immunization Coverage, By Disease, 2014
Table 7 Inadequate Access to Vaccines A Major Challenge in the Market
Table 8 Regulatory Authorities in Europe
Table 9 Regulatory Authorities in Asia
Table 10 Key Pipeline Vaccines
Table 11 Market Size, By Technology, 2014–2021 (USD Million)
Table 12 Conjugate Vaccines Market Size, By Region, 2014–2021 (USD Million)
Table 13 Examples of Inactivated and Subunit Vaccines
Table 14 Inactivated and Subunit Vaccines Market Size, By Region, 2014–2021 (USD Million)
Table 15 Live Attenuated Vaccines Market Size, By Region, 2014–2021 (USD Million)
Table 16 Toxoid Vaccines Market Size, By Region, 2014–2021 (USD Million)
Table 17 Recombinant Vaccines Market Size, By Region, 2014–2021 (USD Million)
Table 18 Vaccines Market Size, By Type, 2014–2021 (USD Million)
Table 19 Monovalent Vaccines Market Size, By Region, 2014–2021 (USD Million)
Table 20 Examples of Multivalent Vaccines
Table 21 Multivalent Vaccines Market Size, By Region, 2014–2021 (USD Million)
Table 22 Market Size, By Disease Indication, 2014–2021 (USD Million)
Table 23 List of Pneumococcal Vaccines
Table 24 Market Size for Pneumococcal Disease, By Region, 2014–2021 (USD Million)
Table 25 List of DTP Vaccines
Table 26 Market Size for DTP, By Region, 2014–2021 (USD Million)
Table 27 List of Influenza Vaccines
Table 28 Market Size for Influenza, By Region, 2014–2021 (USD Million)
Table 29 List of Hpv Vaccines
Table 30 Market for Hpv, By Region, 2014–2021 (USD Million)
Table 31 List of Meningococcal Vaccines
Table 32 Market Size for Meningococcal Disease, By Region, 2014–2021 (USD Million)
Table 33 List of Polio Vaccines
Table 34 Polio Market Size, By Region, 2014–2021 (USD Million)
Table 35 List of Rotavirus Vaccines
Table 36 Market Size for Rotavirus, By Region, 2014–2021 (USD Million)
Table 37 List of Hepatitis Vaccines
Table 38 Market Size for Hepatitis, By Region, 2014–2021 (USD Million)
Table 39 List of MMR Vaccines
Table 40 Market Size for MMR, By Region, 2014–2021 (USD Million)
Table 41 List of Varicella Vaccines
Table 42 Market Size for Varicella, By Region, 2014–2021 (USD Million)
Table 43 List of Other Vaccines
Table 44 Market Size for Other Diseases, By Region, 2014–2021 (USD Million)
Table 45 Market Size, By End User, 2014–2021 (USD Million)
Table 46 Market Size for Pediatrics, By Region, 2014–2021 (USD Million)
Table 47 North America: Market Size for Pediatrics, By Country, 2014–2021 (USD Million)
Table 48 Market Size for Adults, By Region, 2014–2021 (USD Million)
Table 49 North America: Market Size for Adults, By Country, 2014–2021 (USD Million)
Table 50 Market Size, By Region, 2014–2021 (USD Million)
Table 51 North America: Market Size, By Country, 2014–2021 (USD Million)
Table 52 North America: Market Size, By Technology, 2014–2021 (USD Million)
Table 53 North America: Vaccines Market Size, By Type, 2014–2021 (USD Million)
Table 54 North America: Vaccines Market Size, By Disease Indication, 2014–2021 (USD Million)
Table 55 North America: Vaccines Market Size, By End User, 2014–2021 (USD Million)
Table 56 U.S.: Vaccines Market Size, By Technology, 2014–2021 (USD Million)
Table 57 U.S.: Vaccines Market Size, By End User, 2014–2021 (USD Million)
Table 58 Canada: Vaccines Market Size, By Technology, 2014–2021 (USD Million)
Table 59 Canada: Vaccines Market Size, By End User, 2014–2021 (USD Million)
Table 60 Europe: Vaccines Market Size, By Country, 2014–2021 (USD Million)
Table 61 Europe: Vaccines Market Size, By Technology, 2014–2021 (USD Million)
Table 62 Europe: Vaccines Market Size, By Type, 2014–2021 (USD Million)
Table 63 Europe: Vaccines Market Size, By Disease Indication, 2014–2021 (USD Million)
Table 64 Europe: Vaccines Market Size, By End User, 2014–2021 (USD Million)
Table 65 Germany: Vaccines Market Size, By Technology, 2014–2021 (USD Million)
Table 66 U.K.: Vaccines Market Size, By Technology, 2014–2021 (USD Million)
Table 67 France: Vaccines Market Size, By Technology, 2014–2021 (USD Million)
Table 68 Italy: Vaccines Market Size, By Technology, 2014–2021 (USD Million)
Table 69 Spain: Vaccines Market Size, By Technology, 2014–2021 (USD Million)
Table 70 RoE: Vaccines Market Size, By Technology, 2014–2021 (USD Million)
Table 71 Asia: Health Expenditure Per Capita, By Country, 2000 & 2014 (USD)
Table 72 Asia: Vaccines Market Size, By Country, 2014–2021 (USD Million)
Table 73 Asia: Vaccines Market Size, By Technology, 2014–2021 (USD Million)
Table 74 Asia: Vaccines Market Size, By Type, 2014–2021 (USD Million)
Table 75 Asia: Vaccines Market Size, By Disease Indication, 2014–2021 (USD Million)
Table 76 Asia: Vaccines Market Size, By End User, 2014–2021 (USD Million)
Table 77 Japan: Vaccines Market Size, By Technology, 2014–2021 (USD Million)
Table 78 China: Vaccines Market Size, By Technology, 2014–2021 (USD Million)
Table 79 India: Vaccines Market Size, By Technology, 2014–2021 (USD Million)
Table 80 RoA: Vaccines Market Size, By Technology, 2014–2021 (USD Million)
Table 81 RoW: Vaccines Market Size, By Technology, 2014–2021 (USD Million)
Table 82 RoW: Vaccines Market Size, By Type, 2014–2021 (USD Million)
Table 83 RoW: Vaccines Market Size, By Disease Indication, 2014–2021 (USD Million)
Table 84 RoW: Vaccines Market Size, By End User, 2014–2021 (USD Million)
Table 85 Agreements, Collaborations, and Partnerships, 2013-2016
Table 86 Regulatory Approvals, 2013-2016
Table 87 Acquisitions, 2013-2016
Table 88 Expansions, 2013-2016
Table 89 Other Developments, 2013-2016
List of Figures (55 Figures)
Figure 1 Vaccines Market Segmentation
Figure 2 Research Design
Figure 3 Top-Down Approach
Figure 4 Bottom-Up Approach
Figure 5 Breakdown of Primary Interviews: By Company Type, Designation, and Region
Figure 6 Data Triangulation Methodology
Figure 7 Vaccines Market Size, By Technology, 2016 vs 2021 (USD Million)
Figure 8 Global Vaccines Market Size, By Type, 2016 vs 2021 (USD Million)
Figure 9 Global Vaccines Market, By Disease Indication, 2016
Figure 10 Global Vaccines Market Size, By End User, 2016 vs 2021 (USD Million)
Figure 11 Global Vaccines Market, By Region, 2016 (USD Million)
Figure 12 High Prevalence of Diseases and Rising Government & Non-Government Funding for Vaccine Development Primary Growth Drivers for the Global Vaccines Market
Figure 13 Monovalent Vaccines Segment to Witness High Growth During the Forecast Period
Figure 14 Pediatrics Segment to Dominate the Vaccines Market in 2021
Figure 15 Conjugate Vaccines Segment to Account for the Largest Market Share in 2016
Figure 16 U.S. to Dominate the Vaccines Market in 2016
Figure 17 Asia to Witness the Highest Growth Rate in the Vaccines Market During the Forecast Period
Figure 18 Vaccine Market Segmentation
Figure 19 Vaccine Market: Drivers, Restraints, Opportunities, and Challenges
Figure 20 Investors Play an Important Role in the Vaccines Market
Figure 21 Vaccine Funding, By Investor, 2014
Figure 22 Gavi Vaccine Funding, By Type of Investor, 2014
Figure 23 HIV Preventive Vaccines R&D Funding, By Investor, 2014
Figure 24 Regulatory Approval Process for Vaccines
Figure 25 North America Accounted for the Largest Number of Patent Filings in 2012
Figure 26 The U.S. Accounted for Largest Number of Patent Filings Across the Globe (2012)
Figure 27 Conjugate Vaccines Segment to Dominate the Vaccines Market During the Forecast Period
Figure 28 Asian Market for Live Attenuated Vaccines to Register the Highest CAGR During the Forecast Period
Figure 29 North America is Expected to Dominate the Recombinant Vaccines Market During the Forecast Period
Figure 30 Monovalent Vaccines to Dominate the Global Vaccines Market From 2016 to 2021
Figure 31 North America is Expected to Dominate the Multivalent Vaccines Market During the Forecast Period
Figure 32 Pneumococcal Disease Segment Expected to Dominate the Market During the Forecast Period
Figure 33 Asia is Expected to Grow at the Highest CAGR in the Influenza Disease Segment During the Forecast Period
Figure 34 North America to Dominate the Meningococcal Disease Market During the Forecast Period
Figure 35 Asian Market for Hepatitis Vaccines to Grow at the Highest CAGR During the Forecast Period
Figure 36 The Pediatrics End-User Segment Dominates the Global Vaccines Market in 2016
Figure 37 Asia to Witness the Highest Growth Rate in the Vaccines Market for Adults During the Forecast Period
Figure 38 Geographic Snapshot (2016): Emerging Markets to Offer Growth Opportunities
Figure 39 Geographic Benchmarking for Vaccines Technology Market
Figure 40 North America: Vaccines Market Snapshot, 2016
Figure 41 Europe: Vaccines Market Snapshot, 2016
Figure 42 Asia: Vaccines Market Snapshot, 2016
Figure 43 Organic and Inorganic Growth Strategies Adopted By Key Market Players From 2013 to 2016
Figure 44 Global Vaccines Market Share, By Key Player, 2015
Figure 45 Battle for Market Share: Agreements, Collaborations, and Partnerships Were the Preferred Strategies By Market Players
Figure 46 Product Benchmarking for Top 4 Market Players
Figure 47 Pfizer, Inc.: Company Snapshot
Figure 48 Glaxosmithkline, PLC.: Company Snapshot
Figure 49 Merck & Co., Inc.: Company Snapshot
Figure 50 Sanofi Pasteur: Company Snapshot
Figure 51 CSL Limited: Company Snapshot
Figure 52 Emergent Biosolutions: Company Snapshot
Figure 53 Johnson & Johnson: Company Snapshot
Figure 54 Astrazeneca : Company Snapshot
Figure 55 Astellas Pharma Inc.: Company Snapshot
【レポート販売概要】
■ タイトル：ワクチンの世界市場：弱毒生ワクチン、トキソイドワクチン、結合型ワクチン、不活化＆サブユニットワクチン、組換え型ワクチン■ 英文：Vaccines Market by Technology (Live Attenuated, Toxoid, Conjugate, Inactivated & Subunit, Recombinant), Disease Indication (Pneumococcal, Influenza, HPV, Hepatitis, Rotavirus, DTP, Polio, MMR), End User (Pediatrics, Adults) & Type - Forecasts to 2021
■ 発行日：2016年8月9日
■ 調査会社：MarketsandMarkets
■ 商品コード：BT-3113
■ 調査対象地域：グローバル
- スマート・ウェアラブル・エンターテイメント端末及びサービスの世界市場：スマートウォッチ、スマートグラスAbout Smart Wearable Entertainment Devices and Services Smart wearable entertainment devices are used for entertainment and gaming. Some of the entertainment devices include smart watches, smart glasses, wearable hands, wrist bands, head mounted displays, and thumb-work devices. These devices are used to play virtual and 3D games, listen to music and stream videos with augmented reality technology …
- ジオフェンシングの世界市場2019-2023Technavio Announces the Publication of its Research Report – Global Geofencing Market 2019-2023 Technavio recognizes the following companies as the key players in the global geofencing market: Apple Inc., Esri, Localytics, Simpli.fi, Thumbvista. Commenting on the report, an analyst from Technavio’s team said: “The latest trend gaining momentum in the market is the growing applications of geofencin …
- 中東地域のサイバーセキュリティー市場(2014-2019)The protection of valuable intellectual property, and business information in digital form, against theft and misuse, is a critical need for all businesses. The Middle Eastern Countries have identified cyber security, as one of the major concern. Over the past few years, most of the large organizations in this region including giant oil and gas, utilities and banks have strengthened their cyber se …
- Angiomax（ACS/急性冠症候群）：医薬品市場予測及び分析（～2023）Angiomax (Acute Coronary Syndrome) - Forecast and Market Analysis to 2023 Summary GlobalData has released its new PharmaPoint Drug Evaluation report, “Angiomax (Acute Coronary Syndrome) - Forecast and Market Analysis to 2023”. The current ACS market - primarily comprised of antithrombotics, antihypertensives, and statins - is flush with well-established standard-of-care therapies, many of which ar …
- 自動車用コネクタの世界市場2016-2020About Automotive Connectors A connector is a device that transmits electric signals either from the power source to the electronic equipment or connects the internal controls of a machine. It forms a medium of communication between different systems and components by connecting electric circuits with each other. Technavio’s analysts forecast the global automotive connectors market to grow at a CAG …
- 世界のAmino Acids市場動向（2012-2016）TechNavio’s analysts forecast the Global Amino Acids market to grow at a CAGR of 25.5 percent over the period 2012-2016. One of the key factors contributing to this market growth is the increasing demand for amino acid-based dietary supplements. The Global Amino Acids market has also been witnessing an increase in mergers and acquisitions. However, stringent government regulatory norms for the app …
- オイルサンドの世界市場2015-2025The oil sands market will experience a dramatic downturn in 2015 as the impact of the oil price fall impacts upon project economics and company budgets. An almost equally significant decline will be seen in 2018 as the last under-construction oil sands mining and upgrading projects are completed. The extent to which oil sands investment recovers over subsequent years will be highly dependent upon …
- 生体触媒作用・生体触媒の世界市場2016-2020About Biocatalysis and Biocatalysts Biocatalysis is a chemical process in which enzymes and other biological catalysts are used to speed up the reaction between organic components. These enzymes are derived from microorganisms or plant and animal cells. The use and penetration of biocatalysts are increasing in industries, such as agriculture and feed, textile, biofuel production, and biopharmaceut …
- フルフリルアミンの世界市場Ceramide (CAS 100403-19-8) Market Research Report 2013 presents comprehensive data on ceramide markets globally and regionally (Europe, Asia, North America etc.) The Ceramide (CAS 100403-19-8) Market Research Report 2013 includes ceramide description, covers its application areas and related patterns. It overviews ceramide market, names ceramide producers and indicates its suppliers. Besides, the …
- Mobile Applications and Widgets: Portable Applications on Mobile Platforms, Fourth EditionMobile Applications and Widgets: Portable Applications on Mobile Platforms, Fourth Edition provides a complete understanding of the mobile software marketplace. The reader will learn about mobile applications from the inception and evolution of applications on mobile platforms, to current market trends. The state of the current market is defined through current market statistical data, financial a …
- 中圧ケーブルの世界市場：架空ケーブル、地下ケーブル、海底ケーブルGlobal medium voltage cable market was valued at USD 33.8 billion in 2014 and is projected to reach USD 48.8 billion by 2020, at a CAGR of 6.8% during the forecast period 2015 to 2020. The report offers detailed analysis of medium voltage cable market, with regards to the current scenario and the trends prevailing in the industry. The market has been analyzed geographically and is segmented into m …
- ロボット燃料補給システムの世界市場予測（～2030年）“Robotic refueling system market projected to grow at CAGR of 50.0% during forecast period” The robotic refueling system market is expected to grow from USD 25 million in 2019 to USD 2.2 billion by 2030, at a CAGR of 50.0% during forecast period. The growing requirement for low-cost mining operations and the need for improved security and safety, while fuel dispensation are the key factors driving …
- 人工手関節全置換術：企業と競争環境MediPoint: Total Wrist Reconstruction - Current and Future Players Summary Wrist arthritis is a serious issue that affects a significant number of people and making it difficult to engage in many day to day activities. While it is most prevalent in the developed nations, it is a growing concern in the emerging markets as well. The primary indications that have caused wrist arthritis are osteoarthr …
- 傍神経節腫(頸静脈毬腫瘍)(Paraganglioma (Glomus Jugulare Tumor))の治療薬パイプライン動向（2015年上半期版）Paraganglioma (Glomus Jugulare Tumor) - Pipeline Review, H1 2015 Summary Global Markets Direct’s, ‘Paraganglioma (Glomus Jugulare Tumor) - Pipeline Review, H1 2015’, provides an overview of the Paraganglioma (Glomus Jugulare Tumor)’s therapeutic pipeline. This report provides comprehensive information on the therapeutic development for Paraganglioma (Glomus Jugulare Tumor), complete with comparati …
- ビジネス分析ソフトウェアの世界市場：クエリーレポート/分析ツール、コンテンツ分析、データ・ウェアハウジング、ロケーションインテリジェンスBusiness Analytics market is getting hold in the global market due to the increasing demand by businesses to get insight from huge volume of data. These data are arises due to the activities of the customers, products, competitors and through various digital channels involved in business giving rise to the big data trend. It allows the organizations deep dive into the historical and real time data …
